Alison Nolan is currently the Associate Director of Global Regulatory Affairs for the Americas in Cardio Metabolic Health at Eli Lilly and Company, a position held since 2024. With over 20 years of experience in drug metabolism and pharmacokinetics (DMPK), Alison previously served as a Senior Pharmacokinetist at Almac Group from 2009 to 2023 and as a Senior Pharmacokineticist at Elan from 1998 to 2003. They also held a post-doctoral researcher position at University College Cork, Ireland, focusing on the toxicology of nutritional compounds from 1995 to 1998. Alison's educational background includes ongoing studies in MSc Pharmaceutical Technology at Trinity College Dublin and a BSc (Hons) in Biomedical Sciences at Ulster University, along with recent qualifications in D.Phil. in Diabetes and glucose toxicity and a Professional Diploma in Leadership and Management.
This person is not in the org chart
This person is not in any teams
This person is not in any offices